Urine DNA test may let some bladder cancer patients stop immunotherapy early
NCT ID NCT07475403
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a urine DNA test can help guide when to stop immunotherapy in people with a very high-risk type of bladder cancer that cannot be fully removed by surgery. About 53 participants will receive immunotherapy and then be monitored with urine tests and scans. If the urine DNA test and other checks show no cancer, they may stop treatment early and enter active surveillance, aiming to reduce unnecessary therapy while keeping the cancer under control.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Second Hospital of Tianjin Medical University
RECRUITINGTianjin, 300000, China
-
Tianjin Hospital
RECRUITINGTianjin, China
-
Xingtai People's Hospital
RECRUITINGXingtai, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Bag-Like device pull bladder tumors out whole?
- Can Pre-Surgery chemotherapy outsmart aggressive bladder cancer?
- Sound waves could make brain tumor diagnosis safer and smarter
- Bladder cancer: a new combo aims to avoid radical surgery
- Could a simple urine test spare bladder cancer patients from chemotherapy?
- Can a new drug rally the immune system against Hard-to-Treat cancers?